Virosome and ISCOM vaccines against Newcastle disease: Preparation, characterization and immunogenicity

European Journal of Pharmaceutical Sciences

Volumn 22, Issue 5, 2004, Pages 459-468

  Homhuan, Atthachai ^a   Prakongpan, Sompol ^a   Poomvises, Prachak ^b   Maas, Riks A ^c   Crommelin, Daan J A ^d   Kersten, Gideon F A ^e   Jiskoot, Wim ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

^e NETHERLANDS VACCINE INSTITUTE   (Netherlands)

Author keywords

Chol; cholesterol; CMC; critical micelle concentration; DLS; dynamic light scattering; egg phosphatidylcholine; EPC; F protein; fusion protein; HA; haemagglutination activity; HAU; HBS; hepes buffered saline; immunostimulating complexes; ISCOMs

Indexed keywords

ANTIGEN; CHOLESTEROL; ENVELOPE PROTEIN; HN PROTEIN; HYBRID PROTEIN; ISCOM; NEWCASTLE DISEASE VACCINE; OCTYL GLUCOSIDE; PHOSPHOLIPID DERIVATIVE; QUIL A; TRITON X 100; VIROSOME VACCINE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BIRD DISEASE; CHICKEN; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SOLUBILITY; ERYTHROCYTE GHOST; HEMAGGLUTINATION; IMMUNIZATION; IMMUNOGENICITY; MALE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHICKENS; ISCOMS; MALE; NEWCASTLE DISEASE; VACCINES, VIROSOME; VIRAL VACCINES;

EID: 3242703841     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2004.05.005     Document Type: Article

References (37)

1. Alexander, D.J., 1988. Newcastle disease diagnosis. In: Alexander, D.J. (Ed.), Newcastle Disease. Kluwer Academic Publishers, London, pp. 147-160.
2. Alexander D.J. Newcastle disease. Br. Poult. Sci. 42:2001;5-22
3. Allan, W.H., Lancaster, J.E., Toth, B., 1978. Newcastle Disease Vaccines, their Production and use, FAO of the United Nations, Rome.
4. Bachmann M.F., Rohrer U.H., Kundig T.M., Burki K., Hengartner H., Zinkernagel R.M. The influence of antigen organization on B cell responsiveness. Science. 262:1993;1448-1451
5. Bachmann M.F., Zinkernagel R.M. The influence of virus structure on antibody responses and virus serotype formation. Immunol. Today. 17:1996;553-558
6. Barr I.G., Mitchell G.F. ISCOMs (immunostimulating complexes): the first decade. Immunol. Cell. Biol. 74:1996;8-25
7. Bowersock T.L., Martin S. Vaccine delivery to animals. Adv. Drug. Deliv. Rev. 38:1999;167-194
8. Bron R., Ortiz A., Dijkstra J., Stegmann T., Wilschut J. Preparation, properties and applications of reconstituted influenza virus envelopes (virosomes). Methods Enzymol. 220:1993;313-331
9. Bungener L., Serre K., Bijl L., Leserman L., Wilschut J., Daemen T., Machy P. Virosome-mediated delivery of protein antigens to dendritic cells. Vaccine. 20:2002;2287-2295
10. Chackerian B., Lenz P., Lowy D.R., Schiller J.T. Determinants of autoantibody induction by conjugated Papillomavirus virus-like particles. J. Immunol. 169:2002;6120-6126
11. Cobaleda C., García-Sastre A., Villar E. Fusion between Newcastle disease virus and erythrocyte ghosts using octadecyl Rhodamine B fluorescence assay produces dequenching curves that fit the sum of two exponentials. Biochem. J. 300:1994;347-354
12. Cobaleda C., Muñoz-Barroso I., Sagrega A., Villar E. Fusogenic activity of reconstituted Newcastle disease virus envelopes: a role for the haemagglutinin-neuraminidase protein in the fusion process. Int. J. Biochem. Cell. Biol. 1201:2001;1-12
13. Droual R., Bickford A.A., Charlton B.R., Kuney D.R. Investigation of problems associated with intramuscular breast injection of oil-adjuvanted killed vaccines in chickens. Avian. Dis. 34:1990;571-574
14. Glück R., Metcalfe I.C. Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems. Vaccine. 21:2003;611-615
15. Goddard R.D., Nicholas R.A.J., Luff P.R. Serology based potency test for inactivated Newcastle disease vaccines. Vaccine. 6:1988;530-532
16. Huckriede A., Bungener L., ter Veer W., Holtrop M., Daemen T., Palache A.M., Wilschut J. Influenza virosomes: combining optimal presentation of haemagglutinin with immunopotentiating activity. Vaccine. 21:2003;925-931
17. Jiskoot W., Teerlink T., Beuvery E.C., Crommelin D.J.A. Preparation of liposomes via detergent removal from mixed micelles by dilution: The effect of bilayer composition and process parameters on liposome characteristics. Pharm. Weekbl. Sci. Ed. 8:1986;259-265
18. Kapczynski D.R., Tumpey T.M. Development of a virosome vaccine for Newcastle disease virus. Avian. Dis. 47:2003;578-587
19. Kersten G.F.A., Crommelin D.J.A. Liposomes and ISCOMs. Vaccine. 21:2003;915-920
20. King, D.J., 1996. Newcastle Disease: still a worldwide threat to poultry. Zootechnica 76-77.
21. Maas R., Komen M., van Diepen M., Oei H., Claassen I.J.T.M. Correlation of haemagglutinin-neuraminidase and fusion protein content with protective antibody response after immunisation with inactivated Newcastle disease vaccines. Vaccine. 21:2003;3137-3142
22. Maas R.A., Winter M.P.M., Venema S., Oei H. Antigen quantification as in vitro alternative for potency testing of inactivated viral poultry vaccines. Vet. Q. 22:2000;223-227
23. Merz D.C., Scheid A., Choppin P.W. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J. Exp. Med. 151:1980;275-288
24. Metsikko K., van Meer G., Simons K. Reconstitution of the fusogenic activity of vesicular stomatitis virus. EMBO J. 4:1986;2651-2659
25. Morein B., Simons K. Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes. Vaccine. 3:1985;83-93
26. Nagai Y., Hamaguchi M., Toyoda T., Yoshida T. The uncoating of paramyxoviruses may not require a low pH medaited step. Virology. 130:1983;263-268
27. Román K.S., Villar E., Munoz-Barroso I. Acidic pH enhancement of the fusion of Newcastle disease virus with cultured cells. Virology. 260:1999;329-341
28. Rouser G., Fleischer S., Yamamoto A. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorous analysis of spots. Lipids. 5:1970;494-496
29. Seal B.S., King D.J., Sellers H.S. The avian response to Newcastle disease virus. Dev. Comp. Immunol. 24:2000;257-268
30. Singh M., O'Hagan D. Recent advances in veterinary vaccine adjuvants. Int. J. Parasitol. 33:2003;469-478
31. Stegmann T., Morselt H.W., Booy F.P., van Breemen J.F., Wilschut J. Functional reconstitution of influenza virus envelopes. EMBO J. 6:1987;2651-2659
32. Stegmann T., Schoen P., Bron R., Wey J., Bartoldus I., Ortiz A. Evaluation of viral membrane fusion assays. Comparison of the octadecylrhodamine dequenching assay with the pyrene excimer assay. Biochemistry. 32:1993;11310-11337
33. Trybala E. Fusion of erythrocytes by Newcastle disease virus. Acta. Virol. 31:1987;175-179
34. Westbury H. Newcastle disease virus: an evolving pathogen? Avian. Path. 30:2001;117-128
35. White J., Kielian M., Helenius A. Membrane fusion proteins of enveloped animal viruses. Q. Rev. Biophys. 16:1983;151-195
36. Yamanaka M., Okabe T., Nakai M., Goto N. Local pathological reactions and immune response of chickens to ISA-70 and other adjuvants containing Newcastle disease virus antigen. Avian. Dis. 37:1993;459-466
37. Yusoff K., Tan W.S. Newcastle disease virus: macromolecules and opportunities. Avian. Path. 30:2001;439-455